Syneron CFO's surprise departure no cause for alarm, analysts say

Fri, 08/24/2012 - 1:14pm
Mass Device

Syneron CFO Asaf Alperovitz announces a sudden departure to "pursue a new career opportunity," but the move isn't a reflection on the company's financial performance, according to Leerink Swann analysts.

Syneron logo

Investors shouldn't distress over the sudden departure of Syneron Medical (NSDQ:ELOS) chief financial officer Asaf Alperovitz, according to analysts.

The resignation of Alperovitz, who left the company "to pursue a new career opportunity," isn't a "major reason for concern" for the Israel-based aesthetic devices maker, Leerink Swann analysts Richard Newitter and Kathleen McGrath wrote in a note to investors.

"The news is likely to come as a surprise to investors – the timing of these types of  announcements almost always does," the analysts wrote. "We do not view the departure as a function of performance, especially given solid 2Q results (reported last week) which highlighted positive directional progress on the profitability improvement front."


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.